News
Marksans Pharma shares fell 14.28% to ₹180 following a 35.8% YoY drop in net profit to ₹58.2 crore due to weak performances ...
Catalyst Pharmaceuticals stock shines with FIRDAPSE & AGAMREE growth. Learn why the biopharma name is cheap enough to start ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback